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Abstract: We assessed the anti-Listerial activities of crude n-hexane and aqueous extracts 
of Garcinia kola seeds against a panel of 42 Listeria isolates previously isolated from 
wastewater effluents in the Eastern Cape Province of South Africa and belonging to 
Listeria monocytogenes, Listeria grayi and Listeria ivanovii species. The n-hexane fraction 
was active against 45% of the test bacteria with zones of inhibition ranging between   
8–17 mm, while the aqueous fraction was active against 29% with zones of inhibition 
ranging between 8–11 mm. The minimum inhibitory concentrations (MIC) were within the 
ranges of 0.079–0.625 mg/mL  for the n-hexane extract and 10  to  >10 mg/mL  for the 
aqueous extract. The rate of kill experiment carried out for the n-hexane extract only, 
revealed complete elimination of the initial bacterial population for L. grayi (LAL 15) at 3× 
and 4× MIC after 90 and 60 min; L. monocytogenes (LAL 8) at 3× and 4× MIC after 60 and 
15 min; L. ivanovii (LEL 18) at 3× and 4× MIC after 120 and 15 min; L. ivanovii (LEL 30) 
at 2, 3 and 4× MIC values after 105, 90 and 15 min exposure time respectively. The rate of 
kill activities were time-  and concentration-dependant and the extract proved to be 
bactericidal as it achieved a more than 3log10  decrease in viable cell counts after 2 h 
exposure time for all of the four test organisms at 3× and 4× MIC values. The results 
therefore show the potential presence of anti-Listerial compounds in Garcinia kola seeds 
that can be exploited in effective anti-Listerial chemotherapy. 
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The genus Listeria  consists of Gram-positive, non-sporeforming rod shaped bacteria which are 
facultatively anaerobic, catalase positive, oxidase negative and ubiquitous in nature [1]. There are six 
characterized  Listeria species, namely Listeria monocytogenes, Listeria ivanovii, Listeria seeligeri, 
Listeria innocua,  Listeria grayi  and  Listeria welshimeri  [1,2]. Among these six species only two 
species L. ivanovii and L. monocytogenes are regarded as pathogenic; L. monocytogenes is pathogenic 
to humans and animals whilst L. ivanovii is pathogenic to animals mainly sheep and cattle causing the 
bacteremia listeriosis [2,3]. Some studies have however implicated L. seeligeri [4], L. grayi [1,5,6] and 
L. ivanovii in human listeriosis [7,8] and L .innocua in animal listeriosis [9] thereby also showing the 
potential pathogenicity of some of the Listeria species apart from L. monocytogenes and L. ivanovii. 
Listeriosis is a severe food-borne disease characterized by bacteremia, meningitis and encephalitis 
individuals usually at high risk are those with impaired cell-mediated immunity, including neonates, 
pregnant woman, elderly persons, and the immune-compromised patients [10]. L. monocytogenes is an 
invasive, intracellular pathogen that can transverse the placenta in pregnant women and infect the fetus, 
although some intrauterine infection may be the result of ascending spread of the bacteria from vaginal 
colonization resulting in abortion, birth of a stillborn fetus or a baby with generalized infection 
(granulomatosis infantiseptica), and sepsis or meningitis in the neonate such that it is of particular high 
risk for pregnant women [11–13]. 
Listeriosis is regarded as a food-borne disease because most of the listeriosis cases are mainly 
caused by consumption of contaminated food [2,13,14], foods such as ready-to-eat meat products and 
milk products such as cheese [13,15]. In addition to its ubiquitous nature, the Listeria species presents 
a particular concern with respect to food handling because of the ability to grow at temperatures of  
0–45  °C making the species able to grow at refrigerator temperatures commonly used to control 
pathogens in foods. It can also multiply at high salt concentration (10% Sodium chloride) and at pH 
values ranging 4.5–9 [2,16]. 
Standard antibiotic therapy for the effective treatment of listeriosis consists of the intravenous 
administration of penicillin or ampicillin often in combination with an aminoglycoside. The drug of 
choice in patients with  a  known allergy to penicillins is vancomycin/teicoplanin or 
trimethoprim/sulfamethoxazole [15]. Listeriosis has an average case-fatality rate of 20–30% despite 
adequate antibiotic treatment [15] and case fatality rates as high as 40% have been reported during 
outbreaks [11,17]. Epidemiological surveillances have shown the prevalence of antibiotic resistant 
strains of Listeria  species to different antibiotics including those used for the treatment of   
listeriosis [12,18–20]. 
The challenge is therefore to develop effective strategies that may be able to help curb antibiotic 
resistance in such virulent bacteria species such as Listeria. Traditional medicinal plants such as 
Garcinia kola which is a plant of Central and West African origin have been shown to be potential 
sources of anti-bacterial compounds that can be effective against antibiotic resistant bacteria species. 
Garcinia kola is an evergreen, well branched medium-sized tree growing up to 12 metres tall and 1.5 
metres wide in 12 years. It has a regular fruiting cycle and produces a characteristic orange-like pod, 
with edible portion contained in the pod yearly and it belongs to the family Guttiferae  [21–23]. 




traditionally to treat various medicinal ailments such as diarrhoea, hepatitis, asthma, dysmenorrhea, 
diabetes, anaemia, angina, liver disorders and also as an antidote against ingested poison [24,25]. 
Adedeji et al. [22] studies showed that the inclusion of Garcinia kola seed powder into the diet of 
pullet chickens lowered their mortality rate and also caused significant proliferation of the chickens’ 
white blood cells specifically the lymphocytes [22]. Lymphocytes play an important role in cellular 
immunity as they form antibodies that attack antigens in the body; this further supports the traditional 
medicinal value of Garcinia kola  seeds. There have also been studies by various authors that   
have also proven the antimicrobial activities of the seeds of this plant [26–30]. In studies by   
Han et al. [31] an antibacterial biflavonoid 3'',4',4''',5,5'',7,7''-heptahydroxy-3,8''-biflavanone (GB1) was 
isolated from the roots of Garcinia kola  and the GB1 showed antibacterial activities against 
methicillin-resistant  Staphylococcus aureus  (MRSA) and vancomycin-resistant enterococci (VRE) 
[31]. 
The vast medicinal properties and therapeutic potentials of Garcinia kola  seeds and the high 
listeriosis mortality rates in particular against a background of prevalent antibiotic resistant Listeria 
species, prompted this study to evaluate the anti-Listerial properties of the Garcinia kola seed. Despite 
the numerous studies that have been done on this plant, to the best of our knowledge there is no 
information in the literature on the in vitro anti-listerial activities of n-hexane and aqueous extracts of 
the Garcinia kola seed. 
2. Results and Discussion 
2.1. Results 
The results of the anti-Listerial activities of the crude extracts are shown in Table 1. The n-hexane 
extract had activity against 19 isolates whilst the aqueous extract had activity against 12 isolates in 
total with all the isolates that were susceptible to the aqueous extract also being susceptible to the n-
hexane extract. The zones of inhibition ranged from 8–17 mm and 8–11 mm for the n-hexane and 
aqueous extracts respectively at a concentration of 10 mg/mL. The highest zone of inhibition for the n-
hexane extract was 17 mm obtained against L. ivanovii (LEL30) and L. ivanovii (LDB 7) whilst for the 
aqueous extract it was 11 mm obtained against L. ivanovii  (LEL 1). The positive control 
(Ciprofloxacin) and negative control (5% DMSO) were used for quality control purposes, with the 
positive control showing activity against all the isolates with inhibition zones ranging from 9–35 mm 
whilst, the negative control had no activity against all the isolates.  
Table 2 shows the MIC and MBC results for both the extracts against the susceptible Listeria 
isolates. The n-hexane extract had MIC values ranges of 0.079–0.625 mg/mL with a mean value of 
0.218  mg/mL, whilst the MBC values ranges were 0.625–10 mg/mL with a mean value of 8.717 
mg/mL. The aqueous extract had MIC values between 10 to >10 mg/mL and MBC values above 10 
mg/mL for all the isolates. The n-hexane interms of its lower MIC and MBC values proved to be more 
active in comparison to the aqueous extract. 
The results for the rate of kill assay for the n-hexane extract against the four representative Listeria 
species are shown in Figures 1(A),1(B),1(C) and 1(D) with standard deviations included in the curves 




respectively. The rate of kill proved to be both time-  and concentration-dependent for all the 
organisms. A complete bactericidal effect for L. grayi (LAL 15) was achieved at both 3× MIC and 4× 
MIC after 90 and 60 min exposure time. L. monocytogenes’ (LAL 8) entire bacterial population was 
wiped out at both 3× MIC and 4× MIC after 60 and 15 min exposure time respectively. L. ivanovii’s 
(LEL 30) entire bacterial population was eliminated at 2, 3 and 4× MIC values after 105, 90 and 15 
min respectively and a complete bactericidal effect for L. ivanovii (LEL 18) was achieved at 3× MIC 
and 4× MIC values after 120 and 15 min exposure time respectively. The n-hexane extract proved to be 
bactericidal against all the Listeria species giving a more than 3log10 decrease in viable cell counts 
after 2 h exposure time. 
Table 1. The anti-Listerial activities of Ciprofloxacin and the crude n-hexane and aqueous 
extracts of Garcinia kola seeds. 
ORGANISM  N-H  A  C  ORGANISM  N-H  A  C 
L. grayi (LAL 13)  0  0  20 ± 3.055  L. ivanovii (LEL 18)  9 ± 1  8 ± 0  20 ± 3.215 
L. ivanovii (LEL 17)  8 ± 0.577  0  19 ± 1.528  L. ivanovii (LEL 29)  0  0  8 ± 0.577 
L. ivanovii (LEL 30)  17 ± 0.577  0  30 ± 0.577  L. ivanovii (LEL 15)  0  0  13 ± 2.082 
L. ivanovii (LDB 11)  9 ± 0.577  0  20 ± 1  L. ivanovii (LDB 9)  9 ± 1  0  25 ± 2.082 
L. ivanovii (LEL9)  9 ± 0.577  0  16 ± 2.082  L. ivanovii (LDB 10)  13 ± 0  8 ± 0.577  25 ± 0.577 
L. ivanovii (LEL 1)  16 ± 1.155  11 ± 1  17 ± 0.577  L. ivanovii (LEL 2)  0  0  28 ± 1.528 
L. ivanovii (LEL 5)  0  0  11 ± 0.577  L. ivanovii (LEL 6)  0  0  11 ± 1.732 
L. ivanovii (LEL 3)  0  0  35 ± 3.055  L. ivanovii (LEL 4)  0  0  14 ± 1 
L. ivanovii (LEL 19)  0  0  25 ± 4.041  L. ivanovii (LEL 10)  0  0  20 ± 2.082 
L. ivanovii (LAL 9)  11 ± 0.577  0  25 ± 1.732  L. ivanovii (LAL 11)  10 ± 0.577  8 ± 0  17 ± 2.646 
L. grayi (LAL 12)  8 ± 0  0  17 ± 1.155  L. ivanovii (LAL 10)  10 ± 5.77  8 ± 0.577  15 ± 2.082 
L. grayi (LAL 15)  10 ± 2.082  8 ± 0  18 ± 2.082  L. ivanovii (LAL 14)  0  0  30 ± 2.517 
L. ivanovii (LDB 1)  0  0  15 ± 2.082  L. ivanovii (LDB 2)  0  0  14 ± 0 
L. ivanovii (LAL 6)  0  0  19 ± 1.155  L. ivanovii (LAL5)  0  0  20 ± 1.528 
L. ivanovii (LAL 7)  0  0  20 ± 1.528  L. monocytogenes (LAL 8)  13 ± 5.77  10 ± 1.155  12 ± 1 
L. ivanovii (LDB 7)  17 ± 0.577  10 ± 0.577  27 ± 0.577  L. ivanovii (LDB 12)  16 ± 1.528  10 ± 0.577  25 ± 1.528 
L. ivanovii (LDB 3)  11 ± 0  8 ± 0.577  15 ± 1  L. ivanovii (LDB 8)  0  0  20 ± 1.732 
L. ivanovii (LEL 7)  0  0  9 ± 1  L. ivanovii (LEL 8)  0  0  30 ± 1.528 
L. ivanovii (LEL 14)  0  0  35 ± 2  L. ivanovii (LEL 16)  12 ± 1  8 ± 0.577  15 ± 1.528 
L. grayi (LAL 3)  0  0  13 ± 3.055  L. ivanovii (LAL 4)  0  0  20 ± 2 
L. ivanovii (LAL 2)  13 ± 2.082  8 ± 0.577  16 ± 1  L. ivanovii (LAL 1)  0  0  20 ± 2 
(number ± number) denotes mean of three replicates zone of inhibition diameter in mm± standard deviation in 




Table 2.  The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) of crude  n-hexane and aqueous extracts of Garcinia kola  seeds 
against susceptible Listeria isolates. 
Organism 
Extracts 
n-Hexane  Aqueous 
MIC (mg/mL)  MBC (mg/mL)  MIC (mg/mL)  MBC (mg/mL) 
L. ivanovii (LEL9)  0.079  10  _  _ 
L. ivanovii (LEL 18)  0.079  10  10  >10 
L. ivanovii (LAL 10)  0.157  10  10  >10 
L. ivanovii (LEL 30)  0.157  0.625  _  _ 
L. ivanovii (LEL 16)  0.157  10  10  >10 
L. monocytogenes (LAL 8)  0.079  5  10  >10 
L. ivanovii (LDB 12)  0.157  5  >10  >10 
L. ivanovii (LDB 10)  0.079  10  10  >10 
L. ivanovii (LEL 1)  0.157  10  >10  >10 
L. ivanovii (LAL 11)  0.625  10  10  >10 
L. ivanovii (LDB 3)  0.079  10  10  >10 
L. grayi (LAL 15)  0.079  10  10  >10 
L. grayi (LAL 12)  0.625  10  _  _ 
L. ivanovii (LDB 11)  0.079  10  _  _ 
L. ivanovii (LAL 2)  0.157  10  10  >10 
L. ivanovii (LEL 17)  0.625  10  _  _ 
L. ivanovii (LDB 7)  0.079  10  10  >10 
L. ivanovii (LDB 9)  0.625  5  _  _ 
L. ivanovii (LAL 9)  0.079  10  _  _ 
Key: _ denotes not determined 
Figure 1. (A) Profile of rate of kill of L. grayi (LAL 15) by crude n-hexane extracts of  
Garcinia kola seeds; (B) Profile of rate of kill of L. monocytogenes (LAL 8) by crude n-
hexane extracts of Garcinia kola seeds; (C) Profile of rate of kill of L. ivanovii (LEL 30) by 
crude n-hexane extracts of Garcinia kola seeds; (D) Profile of rate of kill of L. ivanovii 
(LEL 18) by crude n-hexane extracts of Garcinia kola seeds. 
 












The crude n-hexane and aqueous extracts of Garcinia kola seeds showed appreciable anti-Listerial 
activities from the susceptibility tests results with the n-hexane extract achieving a 45% activity which 
was higher in comparison to a 29% activity of the aqueous extract. The MIC and MBC ranges of the  




the aqueous extract had higher values with MIC and MBC ranges of 10 to >10 mg/mL and above  
10  mg/mL  respectively. These results corroborates other reports  [28,32–35]  that  showed  that the 
organic solvents extracts of Garcinia kola seeds are more antibacterial in comparison to the aqueous 
extracts, mainly because of the better solubility of the antibacterial agents in Garcinia kola such as 
xanthones, benzophenones, and flavonoids [31,36,37] in organic solvents than in water [29,34,38–40]. 
Some studies on the antibacterial activities of the crude aqueous extracts of Garcinia kola seeds 
have shown MIC values within the ranges of 5–20 mg/mL [28,29,33]. Similarly, in our findings,  
10 isolates had MIC values of 10 mg/mL whilst only two had MIC values above 10 mg/mL. Variations 
in the methodologies used in the studies becomes the greatest obstacle in comparing results to give 
concrete evidence of the seeds’ crude aqueous extracts MIC ranges but they however support the use of 
the seeds’  aqueous extracts in traditional medicine to treat various medical conditions that can 
originate from bacterial infections such as diarrhoea, high fever and throat infections [21]. 
Members of the genus Garcinia from the family Guitefferae are considered as a rich and valuable 
source of bioactive compounds [41–44]. In a study by Pereira et al. [43],  three prenylated 
benzophenones namely 7-epi-clusianone, garciniaphenone and guttiferone-a were obtained from silica 
gel chromatography of the hexane extract of powdered Garcinia brasiliensis Mart. fruits and these 
were found to exhibit significant activity on Leishmania  (L.)  amazonensis  and having minimum 
toxicity for mammalian cells [43]. In a separate study involving non-polar solvents petroleum ether and 
ethyl acetate a polyisoprenyl benzophenone (kolanone) was found in the petroleum ether fraction 
whilst a hydroxybiflavanonols was found in the ethyl acetate fraction of Garcinia kola seeds and GB1 
(a hydroxybiflavanonol) was the main component exhibiting activity against bacteria, Candida 
albicans and Aspergillus flavus [45]. The activity of the n-hexane extract in this study can therefore be 
attributed to a number of compounds possibly those mentioned above that can be found in Garcinia 
kola seeds especially those extracted through the use of non-polar solvents such as n-hexane. 
Rate of kill assays show the bactericidal activity or the duration of a bacteriostatic effect of a fixed 
concentration of the antimicrobial agent, thereby providing a clear analysis of the relationship between 
the extent of microbial population mortality and the antimicrobial agent concentration [46,47].The rate 
of kill activity of the n-hexane extract proved to be bactericidal at ×2 (for L. ivanovii (LEL 30) only),  
×3 and ×4 MIC values after 2 h exposure time for all the test organisms, since a reduction of the viable 
bacterial density of ≥99.9% or ≥3log10 in cfu/mL is used as a standard of measurement for bactericidal 
efficacy [48,49]. The acetone extracts [33], methanol extracts [29], butanol and diethyl-ether fractions 
of the methanol extract [50] of Garcinia kola seeds were also found to exhibit bactericidal activities 
against both Gram positive and Gram negative bacteria, with the findings of Akinpelu et al.[50] and 
Sibanda and Okoh [33]  showing a concentration-  and time-dependent killing activity similar to   
this study. 
This study therefore shows the nature of inhibition of the n-hexane extract of Garcinia kola seeds to 
be bactericidal at 3× and 4× MIC values against Listeria  species as well  as being concentration-  




3. Materials and Methods 
3.1. Plant Material 
Garcinia kola seeds ground powder was obtained from the plant material collection of the Applied  
and  Environmental Microbiology Research Group (AEMREG) laboratory, University of Fort Hare 
Alice, South Africa.  
3.2. Preparation of Extracts 
The method of Basri and Fan [51] was used to prepare the solvents extracts. The seed powder  
(100 grams) was steeped in 500 mL of the respective solvent (n-hexane or water) for 48 h with shaking 
in an orbital shaker (Stuart Scientific Orbital Shaker, UK). The resultant extract was centrifuged at 
3000 rpm for 5 min at 4 °C (Beckman Model TJ-6RS Centrifuge, Great Britain), the supernatant was 
then filtered through Whatman No.1 filter paper while the residue was then used in the second 
extraction process with 300 mL of the respective solvents. After which the combined aqueous extract 
was freeze-dried at −50 °C under vacuum, whereas the n-hexane extracts were concentrated under 
reduced pressure using a rotary evaporator at 50 °C. The concentrated extracts were then allowed to dry 
to a constant weight under a stream of air in a fume cupboard at room temperature. Dimethyl 
sulphoxide (DMSO) at a concentration equal to 5% of the total volume which was made up with sterile 
distilled water was used to aid the reconstitution of the dried n-hexane extract when making different 
test concentrations whilst the water extracts were reconstituted in sterile distilled water. 
3.3. Test Listeria Strains 
The test Listeria isolates (42 in all) used in this study were obtained from the culture collection of 
the Applied and Environmental Microbiology Research Group (AEMREG) laboratory at the University 
of Fort Hare, Alice, South Africa. The bacteria were previously isolated from wastewater effluents and 
belonged to three specie groups which are L. ivanovii, L. grayi and L. monocytogenes [20]. 
3.4. Preparation of the Inoculum 
The colony suspension method according to EUCAST [52] was used to prepare the inoculums of 
the test organisms. Briefly, colonies picked from 24 h old cultures grown on nutrient agar plates were 
used to make suspensions of the test organisms in saline solution (0.85% NaCl) to give an optical 
density of approximately 0.1 at 600 nm. The suspension was then diluted a hundred-fold before use. 
3.5. Antibacterial Susceptibility Test 
The sensitivity of each crude extract of the plant was determined using the agar well diffusion 
method as described by [53], with modifications. The prepared bacterial suspension (100 μL) was 
inoculated into sterile molten Mueller-Hinton agar medium at 50 °C in a MacCarthney bottle, mixed 
gently and then poured into a sterile petri dish and allowed to solidify. A sterile 6 mm diameter cork 




approximately 100 μL of 10 mg/mL extract solution taking care to prevent spillage onto the surface of 
the agar medium. The plates were then allowed to stand on the laboratory bench for 1 h to allow proper 
diffusion of the extract into the medium before incubation at 37 °C for 24 h, and thereafter the zones of 
inhibition were observed and measured. Ciprofloxacin (2 μg/mL) was used as a positive control, and 
distilled water was used as the negative control while 5% Dimethyl sulphoxide (DMSO) was also 
tested to determine its effect on each organism. 
3.6. Determination of the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) 
The broth microdilution assay method of EUCAST [52] was used to determine the MICs for the 
susceptible  Listeria  isolates in sterile disposable flat-bottomed 96-well microtiter plates. Two-fold 
serial dilutions using sterile distilled water were carried out from 10 mg/mL stock plant extracts to 
make  nine  test concentrations ranging from 0.039 to 10 mg/mL  for each solvent extract. Double 
strength Mueller-Hinton broth (100 μL) was introduced into all the 96 wells and 50 μL of the varying 
concentrations of the extracts were added in decreasing order along with 50 μL of the test organism 
suspension. Column 1 was used as the sterility wells containing 100 μL of sterile distilled water in 
addition to the 100 μL of Mueller-Hinton broth, column 2 was used as the positive control wells 
containing 100 μL of the broth, 50 μL of Ciprofloxacin and 50 μL of the test organism whilst column 3 
was used as the negative control wells containing 100 μL of the broth, 50 μL sterile distilled water and 
50 μL of the test organism whilst columns 4 to 12 were used as test wells containing 100 μL of the 
broth, 50 μL  of the extract concentration and 50 μL  of the test organism. The plates were then   
incubated at 37 °C for 18–24 h. Results were read visually by adding 40 μL  of 0.2 mg/mL  of  
ρ-iodonitrotetrazolium violet (INT) dissolved in sterile distilled water into each well [54]. A pinkish 
coloration is indicative of microbial growth because of their ability to convert INT to red   
formazan [55]. The MIC was recorded as the lowest concentration of the extract that prevented the 
appearance of visible growth of the organism after 24 h of incubation [52]. 
Sudjana et al.’s method [56] was used to determine the minimum bactericidal concentration (MBC) 
from the MIC broth microdilution assays by subculturing 10 μL volumes from each well that did not 
exhibit growth after 24 h of incubation and spot inoculating it onto fresh Mueller-Hinton agar plates. 
The plates were incubated for 48 h after which the numbers of viable colonies were counted. The MBC 
was deﬁned as the lowest concentration killing more than or equal to 99.9% of the inoculum compared 
with initial viable counts [56]. 
3.7. Rate of Kill Assay 
The time kill assay was done according to the method of Odenholt et al. [57] as described by  
Akinpelu et al. [50]. The selected test Listeria isolates namely L. ivanovii (LEL 18), L. grayi (LAL 15),  
L. monocytogenes (LAL  8) and L. ivanovii  (LEL 30) were used for the rate of kill studies as 
representatives of the Listeria species used in the study. The turbidity of the 18 h old test Listeria was 
first standardized to 10
8 cfu/mL. Four different concentrations of the plant extract were made starting 
from the MIC to 4× MIC value for each test organism. A 0.5 mL volume of known cell density from 




held at room temperature and the rate of kill determined over a period of 2 h. Exactly 0.5 mL volume 
of each suspension was withdrawn at 15 min intervals and transferred to 4.5 mL of nutrient broth 
recovery medium containing 3% “Tween 80” to neutralize the effects of the antimicrobial compound 
carryovers on the test organisms [50]. The suspension was then serially diluted and 0.5 mL was plated 
out for viable counts using the pour plate method. The plates were thereafter incubated at 37 °C for  
48 h. The control plates contained the test organism without the plant extracts. The emergent colonies 
were counted and compared with the counts of the culture control.  
3.8. Statistical Analysis 
SPSS 19.0 version for Windows program (SPSS, Inc.) at a 95% confidence level was used to 
determine the one way ANOVA, means and standard deviations. 
4. Conclusions 
This study revealed the anti-Listerial activities of both the crude n-hexane and aqueous extracts of 
Garcinia kola seeds with the n-hexane extracts being more active and bactericidal. Further studies to 
determine the extracts interactions with standard antibiotics and to also isolate and characterize the 
active principles in the n-hexane extract are subjects of on-going investigation in our group. We 
conclude that Garcinia kola seeds hold promise as a potential source of therapeutic compounds that 
can be exploited in effective anti-Listerial therapy. 
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